QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=369D0FFBC2D87636BB1B0994D6332FBD;jsessionid=86EE8D8B6B703E6EEBA3A5B918311149;jsessionid=49BA9F47674F5003A9EB16565D277BA0;jsessionid=64A2860A58E179D654B41B3CA32D5353;jsessionid=8711F09FF6886861EE51781057652251;jsessionid=F291C25A4EC476D5F065DEA4BC70B6BB;jsessionid=B7CA112B70315155C47878B0824DD956;jsessionid=4AFEEFAFDEE5B161FD82772FF73D7B1C;jsessionid=8EB6A1459EC8D4E609F5630EF372DDC6;jsessionid=32839908E1F537CAF2188761550CD146;jsessionid=3BD2F3CB223A8FC2E09820B143381E30;jsessionid=631111E8C76EECB7481812A4F7051B57 (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=369D0FFBC2D87636BB1B0994D6332FBD;jsessionid=86EE8D8B6B703E6EEBA3A5B918311149;jsessionid=49BA9F47674F5003A9EB16565D277BA0;jsessionid=64A2860A58E179D654B41B3CA32D5353;jsessionid=8711F09FF6886861EE51781057652251;jsessionid=F291C25A4EC476D5F065DEA4BC70B6BB;jsessionid=B7CA112B70315155C47878B0824DD956;jsessionid=4AFEEFAFDEE5B161FD82772FF73D7B1C;jsessionid=8EB6A1459EC8D4E609F5630EF372DDC6;jsessionid=32839908E1F537CAF2188761550CD146;jsessionid=3BD2F3CB223A8FC2E09820B143381E30;jsessionid=631111E8C76EECB7481812A4F7051B57